AKT Health launches AI platform for connected regulatory operations

AKT Health Analytics on July 28, 2026 launched RegXtrakt, an AI-powered platform aimed at unifying regulatory affairs, quality, safety and labelling for life sciences companies. The company says the system is built to reduce fragmented workflows and help teams manage compliance across the full product lifecycle.

Why it matters: - Regulatory teams in pharma, biotech, medical devices and digital health often manage submissions, safety, quality and labelling across separate tools. - That fragmentation can create duplicated work, limited visibility, inconsistent data and compliance risk. - RegXtrakt is designed to bring those functions into one connected operating environment.

What happened: - AKT Health Analytics announced the launch of RegXtrakt on July 28, 2026. - The platform is AI-powered and built for connected regulatory lifecycle management. - The launch took place in Tokyo, Japan. - RegXtrakt is intended to help life sciences organizations manage regulatory activities through a single integrated platform.

The details: - RegXtrakt connects people, processes, documents and regulatory intelligence across the product lifecycle. - The platform uses a shared regulatory data model so modules can operate from the same foundation. - The system covers Regulatory Affairs, Safety, Quality and Labelling. - Regulatory Affairs functions include submissions, registrations, variations, renewals, authority correspondence, commitments and regulatory intelligence. - Safety functions include pharmacovigilance, signal management, case workflows, compliance obligations and ongoing product safety monitoring. - Quality functions include controlled documentation, CAPAs, audits, supplier management, risk management and inspection readiness. - Labelling functions include product information, artwork, multilingual labelling workflows, version control and market-specific compliance requirements. - Hakase AI Coworker is embedded throughout the platform as an AI assistant for regulated life sciences environments. - Hakase supports retrieving regulatory knowledge, summarizing documentation, drafting submission content and authority responses, identifying dossier gaps, analyzing obligations, surfacing compliance risks and supporting decision-making. - Hakase can reference ICH, EMA, FDA and WHO guidance alongside an organization’s own regulatory records. - AI-generated output stays grounded in the organization’s records and is traceable to underlying sources before human review. - RegXtrakt supports country- and authority-specific regulatory processes and multilingual documentation. - The platform is built to scale as companies expand into new markets while keeping standardized processes and end-to-end visibility. - The platform is powered by AKT Health, a global life sciences consulting and technology company founded in 2017. - AKT Health operates in India, Japan, the United States and the UAE. - The company’s broader services span Regulatory Affairs, Clinical Development, Pharmacovigilance, Medical Affairs, HEOR, Market Access and Commercial Strategy. - RegXtrakt has a dedicated site: More information. - AKT Health’s company site is the company’s website. - AKT Health also links to LinkedIn, Facebook, YouTube, X and its blog.

Between the lines: - AKT Health is positioning RegXtrakt as more than a document repository. - The company is tying the product to its consulting background, signaling an attempt to combine software with regulatory expertise. - The emphasis on traceability and human review suggests the platform is meant to fit tightly controlled compliance workflows rather than replace them.

What's next: - AKT Health appears to be targeting organizations that need to standardize regulatory operations across multiple regions and authorities. - The company is also betting that AI can speed day-to-day regulatory work without weakening governance. - Adoption will likely depend on whether RegXtrakt can prove value across live regulatory, quality and safety workflows.

The bottom line: - RegXtrakt is AKT Health’s bid to centralize regulatory operations and add AI-assisted workflow support for highly regulated life sciences teams.